Julia Hornig, PhD

Associate at Gill Jennings & Every LLP
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
UK
Languages
  • English Native or bilingual proficiency
  • German Native or bilingual proficiency
  • Dutch Limited working proficiency
  • French Elementary proficiency

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Credentials

  • Graduate School Teaching Certificate
    -

Experience

  • Gill Jennings & Every LLP
    • United Kingdom
    • Law Practice
    • 100 - 200 Employee
    • Associate
      • Sep 2022 - Present
  • Jones Day
    • United States
    • Law Practice
    • 700 & Above Employee
    • Associate Lawyer
      • May 2021 - Aug 2022

    • Trainee European Patent Attorney
      • Jul 2017 - Aug 2022

  • Bundespatentgericht München
    • Germany
    • Business Consulting and Services
    • 1 - 100 Employee
    • German Patent Attorney Candidate
      • Apr 2020 - Oct 2020
  • Deutsches Patent- und Markenamt
    • German Patent Attorney Candidate
      • Feb 2020 - Mar 2020
  • Texas A&M Health Science Center
    • United States
    • Higher Education
    • 700 & Above Employee
    • Post Doctoral Fellow
      • Jun 2013 - Apr 2017

      McGregor/Choi Lab Development of recombinant Guinea Pig Cytomegaloviruses (knockout or insertion of GOI) using Bacterial Artificial Chromosome (BAC) technology; Generation and isolation of recombinant viruses and subsequent in vitro and in vivo evaluation as potential vaccine candidates; Investigation of cellular innate and intrinsic (ND10 bodies) immunity in CMV infection. McGregor/Choi Lab Development of recombinant Guinea Pig Cytomegaloviruses (knockout or insertion of GOI) using Bacterial Artificial Chromosome (BAC) technology; Generation and isolation of recombinant viruses and subsequent in vitro and in vivo evaluation as potential vaccine candidates; Investigation of cellular innate and intrinsic (ND10 bodies) immunity in CMV infection.

  • Easton Associates
    • United States
    • Business Consulting and Services
    • 1 - 100 Employee
    • Associate Consultant
      • Oct 2010 - May 2012

      Easton Associates was acquired by Navigant in October 2012. Daily work consisted of gathering primary and secondary information and to prepare quantitative analyses to define issues and solutions. Work as associate management consultant in the Life Sciences also focused on the composition of presentations for our clients. Easton Associates was acquired by Navigant in October 2012. Daily work consisted of gathering primary and secondary information and to prepare quantitative analyses to define issues and solutions. Work as associate management consultant in the Life Sciences also focused on the composition of presentations for our clients.

Education

  • FernUniversität in Hagen
    Recht für Patentanwälte
    2018 - 2020
  • Imperial College London
    PhD, Immunology
    2007 - 2011
  • Imperial College London
    MSc, Molecular Biology and Pathogenesis of Viruses
    2006 - 2007
  • University of Toronto
    Honors Bachelor of Science, Human Biology (Genes, Genetics, Biotechnology), Biological Anthropology
    2002 - 2006
  • Landgericht Mannheim
    Internship
    2019 - 2019

Community

You need to have a working account to view this content. Click here to join now